Transforming growth factor-β: master regulator of the respiratory system in health and disease

Y Aschner, GP Downey - American journal of respiratory cell and …, 2016 - atsjournals.org
In this article, we review the biology and physiological importance of transforming growth
factor-β (TGF-β) to homeostasis in the respiratory system, its importance to innate and …

[HTML][HTML] Sex, gender, and sex hormones in pulmonary hypertension and right ventricular failure

J Hester, C Ventetuolo, T Lahm - Comprehensive Physiology, 2019 - ncbi.nlm.nih.gov
Pulmonary hypertension (PH) encompasses a syndrome of diseases that are characterized
by elevated pulmonary artery pressure and pulmonary vascular remodeling and that …

Matrix remodeling promotes pulmonary hypertension through feedback mechanoactivation of the YAP/TAZ-miR-130/301 circuit

T Bertero, KA Cottrill, YU Lu, CM Haeger… - Cell reports, 2015 - cell.com
Pulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins.
We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and …

ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension

LM Yung, P Yang, S Joshi, ZM Augur… - Science translational …, 2020 - science.org
Human genetics, biomarker, and animal studies implicate loss of function in bone
morphogenetic protein (BMP) signaling and maladaptive transforming growth factor–β …

Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle–like cells in pulmonary …

N Ricard, L Tu, M Le Hiress, A Huertas, C Phan… - Circulation, 2014 - Am Heart Assoc
Background—Pericytes and their crosstalk with endothelial cells are critical for the
development of a functional microvasculature and vascular remodeling. It is also known that …

Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension

KR Stenmark, MG Frid, BB Graham… - Cardiovascular …, 2018 - academic.oup.com
Pulmonary hypertension (PH) is the end result of interaction between pulmonary vascular
tone and a complex series of cellular and molecular events termed 'vascular remodelling' …

TGF-β and BMPR2 signaling in PAH: two black sheep in one family

N Rol, KB Kurakula, C Happé, HJ Bogaard… - International journal of …, 2018 - mdpi.com
Knowledge pertaining to the involvement of transforming growth factor β (TGF-β) and bone
morphogenetic protein (BMP) signaling in pulmonary arterial hypertension (PAH) is …

Animal models of pulmonary hypertension: Getting to the heart of the problem

JP Dignam, TE Scott, BK Kemp‐Harper… - British Journal of …, 2022 - Wiley Online Library
Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension

R Kumar, C Mickael, B Kassa, L Gebreab… - Nature …, 2017 - nature.com
Pulmonary arterial hypertension (PAH) is an obstructive disease of the precapillary
pulmonary arteries. Schistosomiasis-associated PAH shares altered vascular TGF-β …

NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension

AO Samokhin, T Stephens, BM Wertheim… - Science translational …, 2018 - science.org
Germline mutations involving small mothers against decapentaplegic–transforming growth
factor–β (SMAD–TGF-β) signaling are an important but rare cause of pulmonary arterial …